Results 161 to 170 of about 436,454 (294)

100Vβ repertoire analysis of tissue infiltrating CD8+ Tcells responding to minor histocompatibility antigens involved in graft-versus-host disease

, 2003
Thea M. Friedman, Delivette Castor, Stephen C. Jones, Robert Korngold   +3 more
openalex   +1 more source

PD‐1 Inhibits CD4+ TRM‐Mediated cDC1 Mobilization via Suppressing JAML in Human NSCLC

Advanced Science, EarlyView.
CD4+ tissue‐resident memory T cells (TRMs) in non‐small cell lung cancer recruit conventional type 1 dendritic cells via XCL1‐XCR1 signaling, orchestrating antitumor immunity. The costimulatory molecule JAML is essential for this process. PD‐1 blockade restores JAML expression and cDC1 mobilization, while JAML agonists synergize with anti‐PD‐1 therapy,
Zheyu Shao, Qinyuan Liu, Zhongwei Xin, Zhiyao Zhou, Mingjie Lin, Di Chen, Zhixing Hao, Yongyuan Chen, Wenxuan Wu, Shuyang Zhang, Xiaoke Chen, Xia Xu, Jinfan Li, Wei Lin, Yuhao Lu, Dang Wu, Pin Wu   +16 more
wiley   +1 more source

CXCR5 identifies stem-like resident memory CD8⁺ T cells enriched for latent EBV specificity in tonsils. [PDF]

Sci Adv
Rivera Ballesteros O, Rieble L, Cai C, Sekine T, Nilsén V, Adamo S, Müller TR, Constantz C, Niessl J, White E, Ko Y, Kammann T, Mouchtaridi E, Gao Y, Mily A, Raineri EJM, Stamper C, Marchalot A, Wild N, Brownlie D, Llewellyn-Lacey S, Tibbitt C, Michaëlsson J, Marquardt N, Mjösberg J, Jorns C, Sandberg JK, Driving J, Price DA, Buggert M.   +29 more
europepmc   +1 more source

Evasion of CD8+ and CD4+ T cell recognition by herpesviruses

, 1999
Roman Tomazin
openalex   +1 more source

Regulating Tumor Metabolic Reprogramming with Biomimetic Co‐Delivery of Simvastatin and Kynureninase for Immunotherapy

Advanced Science, EarlyView.
After the intravenous injection of biomimetic and pH/ROS‐responsive PTSK@CRM, the nanoparticles can be accumulated in tumors and release Sim and KYNase to inhibit the tumor growth, regulate the metabolism of cholesterol and Kyn, and reverse the immunosuppressive tumor microenvironment.
Jiaxin Yin, Shengcai Yang, Zengguang Liu, Songchen Zhao, Siyu Sun, Ziling Liu, Quanshun Li   +6 more
wiley   +1 more source

Modulating CD8⁺ T cell immunity through exercise: mechanistic insights and implications for precision immunotherapy. [PDF]

Theranostics
Zhao X, Chen X, Lin P, Lin Y, Feng W, Zou M, Li N, Cui L.   +7 more
europepmc   +1 more source

Three‐Year Follow‐Up of Neoadjuvant Tislelizumab with Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: Revealing Cancer‐Associated Fibroblast Heterogeneity Corresponding to PD‐1 Blockade Efficacy

Advanced Science, EarlyView.
Heterogeneous cancer‐associated fibroblasts orchestrate dual immune microenvironments in LAGC. Abstract The potential for immunotherapy in patients with locally advanced gastric cancer (LAGC) is recently confirmed. To report the 3‐year follow‐up data are aimed from a novel clinical trial. This is a prospective single‐arm phase II trial.
Yao Lin, Xiong Sun, Chengguo Li, Ming Yang, Ke Wu, Ke Liu, Anshu Li, Xiaoming Shuai, Kailin Cai, Zheng Wang, Guobin Wang, Peng Zhang, Jianfeng Shen, Kaixiong Tao, Yuping Yin   +14 more
wiley   +1 more source

DNA prime and peptide boost immunization elicits robust neoantigen-specific CD8 ⁺ T cell responses and therapeutic protection in mouse tumor models. [PDF]

Oncoimmunology
Morgado-Cáceres P, Hofmann-Vega F, Figueroa D, Saavedra-Almarza J, Gálvez-Cancino F, Díaz X, Menares E, Roa E, Hidalgo S, Varas-Godoy M, Borgna V, Lladser A.   +11 more
europepmc   +1 more source

Reviewer #2 (Public Review): Thymic self-recognition-mediated TCR signal strength modulates antigen-specific CD8+ T cell pathogenicity in non-obese diabetic mice [PDF]

Chia-Lo Ho, Li-Tzu Yeh, Yu-Wen Liu, Jia-Ling Dong, Huey-Kang Sytwu   +4 more
openalex   +1 more source

CD8 Negative [PDF]

, 2020
openaire   +1 more source